ÂÜÀòÂÒÂ×

Sylvie Mireille Guichard is an experienced executive in the field of translational medicine and science, currently serving as Executive Director of Translational Medicine at Novo Nordisk since October 2022. Prior roles include positions at Forma Therapeutics, where responsibilities encompassed Executive Director of Translational Science and Senior Director of Translational Science, and a decade at AstraZeneca, where significant contributions included leading target discovery and validation efforts. Academic experience includes a senior lectureship at the University of Edinburgh and a lecturer position at Université Paul Sabatier. Sylvie Mireille Guichard holds a PhD in Molecular Pharmacology and Toxicology and a PharmD in Pharmacology, complemented by a BSc in Chemistry and Physics.